| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.61B | -5.0% |
| Cost of Revenue | $5.50B | -4.0% |
| Gross Profit | $7.12B | -5.7% |
| R&D Expense | $2.35B | -2.9% |
| SG&A Expense | $1.16B | +0.4% |
| Operating Income | $3.42B | -6.7% |
| Interest Expense | $398.0M | -9.1% |
| Pre-tax Income | $3.10B | -7.5% |
| Income Tax | $545.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.29B | -14.8% |
| Accounts Receivable | $1.03B | +15.4% |
| Inventory | $2.36B | +10.4% |
| Current Assets | $7.30B | -7.1% |
| Total Assets | $24.39B | +0.1% |
| Current Liabilities | $3.10B | -24.6% |
| Long-term Debt | $10.42B | -7.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.78B | -20.8% |
| Capital Expenditures | $727.0M | -12.1% |
| Investing Cash Flow | -$686.0M | +54.5% |
| Financing Cash Flow | -$2.66B | -33.8% |
| Free Cash Flow | $2.06B | -23.5% |
| +4.2% |
| Net Income | $2.51B | -10.3% |
| EPS (Basic) | $9.84 | -9.1% |
| EPS (Diluted) | $9.73 | -9.1% |
| Stockholders' Equity |
| $9.18B |
| +6.2% |